Начало › Множествен миелом › Ню Джърси › Edison
Клинични проучвания за Множествен миелом в Edison, NJ
22 проучвания за Множествен миелом търсят участници в обекти в и около Edison (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Набиране на участнициФаза 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 мили
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Набиране на участнициФаза 3
- Astera Cancer Care, East Brunswick · на 6 мили
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Набиране на участнициФаза 3
- Astera Cancer Care, East Brunswick · на 6 мили
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Набиране на участнициФаза 3
- MSK Basking Ridge, Basking Ridge · на 15 мили
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Набиране на участнициФаза 4
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 мили
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Набиране на участнициФаза 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · на 15 мили
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Набиране на участнициФаза 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 мили
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Набиране на участнициФаза 3
- MSK Basking Ridge, Basking Ridge · на 15 мили
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Набиране на участнициФаза 1
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 мили
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Набиране на участнициФаза 3
- Research Site, East Brunswick · на 6 мили
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Набиране на участнициНаблюдателно проучване
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 мили
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Набиране на участнициФаза 1/2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 мили
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Набиране на участнициФаза 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 мили
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Набиране на участнициФаза 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 мили
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
Набиране на участнициРанна фаза 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 мили
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Brunswick · на 3 мили
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Набиране на участнициФаза 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 мили
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Набиране на участнициФаза 1
- Rutgers Cancer Institute of New Jersey /ID# 266833, New Brunswick · на 3 мили
A Dietary Study for People With Multiple Myeloma
Набиране на участници
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 мили
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Набиране на участнициФаза 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 мили
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Набиране на участнициФаза 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 мили
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 мили
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Набиране на участници
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · на 15 мили
Проучвания за Множествен миелом в други градове
- New York City, NY60 проучвания
- Boston, MA42 проучвания
- Atlanta, GA41 проучвания
- Houston, TX38 проучвания
- Durham, NC37 проучвания
- Nashville, TN32 проучвания
- Denver, CO27 проучвания
- Rochester, MN24 проучвания
- St. Louis, MO24 проучвания
- Columbus, OH24 проучвания
- Baldwin Park, CA23 проучвания
- Chicago, IL22 проучвания
Други проучвания в Edison
- Рак на гърдата68 проучвания
- Рак на белия дроб с недребноклетъчен тип47 проучвания
- Рак (всички видове)33 проучвания
- Рак на простатата29 проучвания
- Колоректален рак23 проучвания
- Рак на белия дроб23 проучвания
- Рак на пикочния мехур21 проучвания
- Метастатичен рак20 проучвания
- Рак на яйчниците20 проучвания
- Остра миелоидна левкемия20 проучвания
- Ендометриален рак19 проучвания
- Уротелиен (преходноклетъчен) карцином18 проучвания
От ClinicalTrials.gov, данни към 5.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.